On January 29, 2025, IMDRF released a significant document titled “Good Machine Learning Practice for Medical Device Development: Guiding Principles.” This publication outlines ten guiding principles designed to promote the development of safe, effective, and high-quality medical devices that incorporate artificial intelligence (AI) and machine learning (ML) technologies. These principles are intended to be applied…
On January 6, 2025, the U.S. Food and Drug Administration (FDA) released a draft guidance aimed at developers of artificial intelligence (AI)-enabled medical devices. This document offers comprehensive recommendations to ensure the safety and effectiveness of AI-driven devices throughout their entire product lifecycle. The guidance emphasizes the importance of transparency and the mitigation of bias…
On Dec. 4, 2024, the U.S. Food and Drug Administration (FDA) issued a final guidance on “Marketing Submission Recommendations for a Predetermined Change Control Plan (PCCP) for Artificial Intelligence-Enabled Device Software Functions.” This guidance provides a framework for manufacturers to proactively plan for modifications to AI-enabled medical devices, ensuring that these updates maintain device safety…
Have questions or looking for expert guidance in healthcare innovation, AI-driven medical devices, regulatory approvals, or strategic partnerships? We’re here to help.
📩 Contact us today to discuss how we can support your business growth, regulatory needs, or clinical strategy. Your privacy is our priority—any information you provide will be used solely to address your inquiry.
🔹 Let’s transform healthcare together..
